285 related articles for article (PubMed ID: 23141735)
1. [p53 gene therapy for oral cancer].
Liu SX; Hu M
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
[No Abstract] [Full Text] [Related]
2. Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1) arrest via the ATM/p53 pathway.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Baek SJ; Lee K; Kim CH
Arch Biochem Biophys; 2014 Mar; 545():133-40. PubMed ID: 24486404
[TBL] [Abstract][Full Text] [Related]
3. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
Fukuda M; Nakatsuka T; Kusama K; Sakashita H
J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
[No Abstract] [Full Text] [Related]
4. Clinical trails referral resource. Clinical trials of adenovirus-p53 gene therapy.
Zwiebel JA; Nagler C; Smiley JK; Cheson BD
Oncology (Williston Park); 1998 Aug; 12(8):1172, 1175. PubMed ID: 11236309
[No Abstract] [Full Text] [Related]
5. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
7. Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
Ichwan SJ; Yamada S; Sumrejkanchanakij P; Ibrahim-Auerkari E; Eto K; Ikeda MA
Oncogene; 2006 Feb; 25(8):1216-24. PubMed ID: 16247456
[TBL] [Abstract][Full Text] [Related]
8. The combination of ionizing radiation and expression of a wild type p53 gene via recombinant adenovirus induced a prominent tumour suppressing effect in human oral squamous cell carcinoma.
Wakasa T; Inoue T; Kawai N; Murakami J; Kishi K; Fukui K
Br J Radiol; 2002 Aug; 75(896):657-62. PubMed ID: 12153939
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of inactive p53 protein in oral squamous cell carcinoma: stabilization by protein interaction.
Francis G; Dileep Kumar U; Nalinakumari KR; Jayasree K; Kannan S
Eur J Oral Sci; 2013 Feb; 121(1):21-8. PubMed ID: 23331420
[TBL] [Abstract][Full Text] [Related]
10. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma.
Kusama K; Okutsu S; Takeda A; Himiya T; Kojima A; Kidokoro Y; Chu L; Iwanari S; Kudo I; Moro I
J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320
[TBL] [Abstract][Full Text] [Related]
11. [p53 mutation and chemoresistance in oral-maxillofacial squamous cell carcinoma. Role of p53 in the cell cycle control and in the modulating action of chemotherapeutic agents].
Cutilli T; Papola F; Di Emidio P; Corbacelli A
Minerva Stomatol; 1997 Dec; 46(12):671-8. PubMed ID: 9567617
[TBL] [Abstract][Full Text] [Related]
12. Head and neck cancer: response to p53-based therapeutics.
Nemunaitis J; Nemunaitis J
Head Neck; 2011 Jan; 33(1):131-4. PubMed ID: 20222046
[TBL] [Abstract][Full Text] [Related]
13. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for head and neck cancers.
Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
17. P53-mutation in smears of oral squamous cell carcinoma.
Friedrich RE; Giese M; Riethdorf S; Loning T
Anticancer Res; 2000; 20(6D):4927-30. PubMed ID: 11326641
[TBL] [Abstract][Full Text] [Related]
18. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide induces oral squamous cell carcinoma cell apoptosis with p53 accumulation [Oral Oncology 41 (8) (2005) 785-790].
Brennan PA
Oral Oncol; 2005 Sep; 41(8):783-4. PubMed ID: 16054425
[No Abstract] [Full Text] [Related]
20. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity.
Tavassoli M; Brunel N; Maher R; Johnson NW; Soussi T
Int J Cancer; 1998 Oct; 78(3):390-1. PubMed ID: 9766578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
